Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Raj Pol"'
Autor:
Jan Soerensen, Grit Herter-Sprie, Zyrafete Kuçi, Erhard Seifried, Gernot Beutel, Jochen Buechner, Martin Hutter, Ansgar Schulz, Aniko Barta, Giovanna Lucchini, Emilia Salzmann-Manrique, Karl-Walter Sykora, Mohammad Ashab Uddin, Mike Dennis, Shahrzad Bakhtiar, Peter Lang, Phil Jenkin, Peter Bader, Andrea Jarisch, Oliver Basu, Paul-Gerhardt Schlegel, Agnes Kelemen, Abdulrahman Alsultan, Shankara Paneesha, Gesine Bug, Neta Nevo, Aharon Gefen, Raj Pol, Johann Greil, Irene von Luettichau, Igor Novitzky-Basso, Thomas Klingebiel, Selim Kuçi, Richard Schäfer, Jerry Stein, Halvard Bonig, Krisztián M. Kállay
Publikováno v:
Cells
Volume 8
Issue 12
Volume 8
Issue 12
(1) Background: Refractory acute graft-versus-host disease (R-aGvHD) remains a leading cause of death after allogeneic stem cell transplantation. Survival rates of 15% after four years are currently achieved
deaths are only in part due to aGvHD
deaths are only in part due to aGvHD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::628108d3be3250f207d2bd92b51a7dd8
https://mediatum.ub.tum.de/1546020
https://mediatum.ub.tum.de/1546020
Autor:
Jan Soerensen, Grit Herter-Sprie, Agnes Kelemen, Raj Pol, Aniko Barta, Erhard Seifried, Emilia Salzmann-Manrique, Thomas Klingebiel, Jerry Stein, Halvard Bonig, Andrea Jarisch, Mike Dennis, Abdulrahman Alsultan, Peter Bader, A. Schulz, Karl-Walter Sykora, Irene von Luettichau, Zyrafete Kuçi, Jochen Buechner, Martin Hutter, Giovanna Lucchini, Gesine Bug, Mohammad Ashab Uddin, Shahrzad Bakhtiar, Peter Lang, Phil Jenkin, Richard Schäfer, Krisztián M. Kállay, Oliver Basu, Johann Greil, Selim Kuçi
Publikováno v:
Bone Marrow Transplantation
The inability to generate mesenchymal stromal cells (MSCs) of consistent potency likely is responsible for inconsistent clinical outcomes of patients with aGvHD receiving MSC products. We developed a novel MSC manufacturing protocol characterized by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dab364af9b22af806b76a5bab16b3ba7
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85041115547
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85041115547
Autor:
Mike Dennis, Krisztián M. Kállay, Peter Bader, Gesine Bug, Karl Walther Sykora, Thomas Klingebiel, Jan Soerensen, Halvard Boenig, Andrea Jarisch, A. Schulz, Irene von Luettichau, Raj Pol, Erhard Seifried, Zyrafete Kuçi, Johann Greil, Emilia Salzmann, Shahrzad Bakhtiar, Peter Lang, Giovanna Luccini, Selim Kuçi, Oliver Basu
Publikováno v:
Cytotherapy. 19:e6-e7
Publikováno v:
Blood. 108:5059-5059
Multiple myeloma is a clonal lymphoproliferative disorder characterised by proliferation of plasma cells in marrow and is associated with an unbalanced bone remodelling leading to osteolytic lesions. Bone marrow interstitial fibrosis is common in mye